Moleculin Biotech Inc
NASDAQ:MBRX

Watchlist Manager
Moleculin Biotech Inc Logo
Moleculin Biotech Inc
NASDAQ:MBRX
Watchlist
Price: 3.83 USD -1.79% Market Closed
Market Cap: 7.9m USD

Intrinsic Value

The intrinsic value of one MBRX stock under the Base Case scenario is 3.25 USD. Compared to the current market price of 3.83 USD, Moleculin Biotech Inc is Overvalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MBRX Intrinsic Value
3.25 USD
Overvaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Moleculin Biotech Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about MBRX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MBRX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Moleculin Biotech Inc.

Explain Valuation
Compare MBRX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MBRX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Moleculin Biotech Inc

Current Assets 7.9m
Cash & Short-Term Investments 6.7m
Receivables 27k
Other Current Assets 1.2m
Non-Current Assets 12.5m
PP&E 420k
Intangibles 11.1m
Other Non-Current Assets 900k
Current Liabilities 5.7m
Accounts Payable 2.1m
Accrued Liabilities 3.6m
Non-Current Liabilities 41.6m
Other Non-Current Liabilities 41.6m
Efficiency

Free Cash Flow Analysis
Moleculin Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Moleculin Biotech Inc

Revenue
0 USD
Operating Expenses
-24.2m USD
Operating Income
-24.2m USD
Other Expenses
-17.1m USD
Net Income
-41.4m USD
Fundamental Scores

MBRX Profitability Score
Profitability Due Diligence

Moleculin Biotech Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

39/100
Profitability
Score

Moleculin Biotech Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

MBRX Solvency Score
Solvency Due Diligence

Moleculin Biotech Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
44/100
Solvency
Score

Moleculin Biotech Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MBRX Price Targets Summary
Moleculin Biotech Inc

Wall Street analysts forecast MBRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MBRX is 6.8 USD with a low forecast of 4.04 USD and a high forecast of 12.6 USD.

Lowest
Price Target
4.04 USD
5% Upside
Average
Price Target
6.8 USD
78% Upside
Highest
Price Target
12.6 USD
229% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Moleculin Biotech Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MBRX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MBRX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MBRX stock?

The intrinsic value of one MBRX stock under the Base Case scenario is 3.25 USD.

Is MBRX stock undervalued or overvalued?

Compared to the current market price of 3.83 USD, Moleculin Biotech Inc is Overvalued by 15%.

Back to Top